Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis (Q43636858)

25 November 2017

title

Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis (English)

1 reference

25 November 2017

0 references

0 references

Sorscher EJ

1 reference

25 November 2017

Clancy JP

1 reference

25 November 2017

Bebök Z

1 reference

25 November 2017

Ruiz F

1 reference

25 November 2017

King C

1 reference

25 November 2017

Jones J

1 reference

25 November 2017

Walker L

1 reference

25 November 2017

Greer H

1 reference

25 November 2017

Hong J

1 reference

25 November 2017

Wing L

1 reference

25 November 2017

Macaluso M

1 reference

25 November 2017

Lyrene R

1 reference

25 November 2017

Bedwell DM

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

25 November 2017

published in

1 reference

25 November 2017

volume

163

1 reference

25 November 2017

1 reference

25 November 2017

page(s)

1683-1692

1 reference

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

Demonstration That CFTR Is a Chloride Channel by Alteration of Its Anion Selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

CFTR as a cAMP-dependent regulator of sodium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

Genotype-phenotype correlations in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

Long-term culture of normal and cystic fibrosis epithelial cells grown under serum-free conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

Cystic fibrosis transmembrane conductance regulator (CFTR) nucleotide-binding domain 1 (NBD-1) and CFTR truncated within NBD-1 target to the epithelial plasma membrane and increase anion permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

Relationship between airway ion transport and a mild pulmonary disease mutation in CFTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

In vitro assessment of variables affecting the efficiency and efficacy of adenovirus-mediated gene transfer to cystic fibrosis airway epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.7.2004001

10.1164/AJRCCM.163.7.2004001

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference